Chantel Wilson Chase

Director, Quality Analytics and Reporting Alexion, AstraZeneca Rare Disease Business Unit

Chantel Wilson Chase has 25 years of experience in data science (quantitative and qualitative) roles at Staples, Brigham and Women’s Hospital, and Harvard Pilgrim Health Plan, among others. She currently leads the Quality Analytics and Reporting division at Alexion, AstraZeneca Rare Disease Business Unit. With employee experience as the underlying foundation of all her work, she focuses on automation, investigations, and deep dive analysis to drive adoption and engagement forward. She holds a Master’s Degree in Applied Sociology and a Bachelor’s Degree in Actuarial Science/Mathematics.